The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127653871 12765387 1 I 20160721 20160921 20160921 EXP DE-DRREDDYS-USA/GER/16/0081971 DR REDDYS KRUGER T, JOCKERS-SCHERUBL M, GROHMANN R, RUTHER E, DEGNER D, MUNICH, ET.AL. DEVELOPMENT OF EPILEPTIC SEIZURES UNDER THERAPY WITH OLANZAPINE AND VENLAFAXINE ER WITH FATAL OUTCOME. PSYCHOPHARMAKOTHERAPIE. 2016;23(3):125-8. 76.00 YR F Y 0.00000 20160921 MD COUNTRY NOT SPECIFIED DE

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127653871 12765387 1 PS VENLAFAXINE VENLAFAXINE HYDROCHLORIDE 1 Unknown D UNKNOWN 78421 37.5 MG
127653871 12765387 2 SS VENLAFAXINE VENLAFAXINE HYDROCHLORIDE 1 Unknown D UNKNOWN 78421 75 MG
127653871 12765387 3 SS VENLAFAXINE VENLAFAXINE HYDROCHLORIDE 1 Unknown D UNKNOWN 78421 112.5 MG
127653871 12765387 4 SS amitriptyline AMITRIPTYLINE 1 Unknown 0 30 MG
127653871 12765387 5 SS OLANZAPINE. OLANZAPINE 1 Oral D 0 5 MG
127653871 12765387 6 SS OLANZAPINE. OLANZAPINE 1 Oral D 0 2.5 MG
127653871 12765387 7 SS dabigatran DABIGATRAN 1 Oral D 0
127653871 12765387 8 SS PREDNISOLONE. PREDNISOLONE 1 Unknown 0
127653871 12765387 9 SS PREDNISOLONE. PREDNISOLONE 1 0 2.5 MG
127653871 12765387 10 SS LORAZEPAM. LORAZEPAM 1 Unknown 0 .75 MG
127653871 12765387 11 SS LORAZEPAM. LORAZEPAM 1 0 1 MG
127653871 12765387 12 SS LORAZEPAM. LORAZEPAM 1 0 .5 MG
127653871 12765387 13 SS LORAZEPAM. LORAZEPAM 1 0 .25 MG
127653871 12765387 14 SS fesoterodine FESOTERODINE 1 Unknown 0
127653871 12765387 15 SS colecalciferol CHOLECALCIFEROL 1 Unknown 0 .75 MG /wk
127653871 12765387 16 C pantoprazole PANTOPRAZOLE SODIUM 1 Unknown 0
127653871 12765387 17 C METHOTREXATE. METHOTREXATE 1 Unknown 0 15 MG /wk
127653871 12765387 18 C calcium CALCIUM 1 Unknown 0
127653871 12765387 19 C oxycodone OXYCODONE 1 Unknown 0
127653871 12765387 20 C doxepin DOXEPIN 1 Unknown 0 25 MG
127653871 12765387 21 C naloxone NALOXONE 1 Unknown 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127653871 12765387 1 Depression
127653871 12765387 4 Insomnia
127653871 12765387 5 Deep vein thrombosis
127653871 12765387 7 Deep vein thrombosis
127653871 12765387 8 Merycism
127653871 12765387 10 Depression
127653871 12765387 14 Depression
127653871 12765387 15 Depression
127653871 12765387 16 Depression
127653871 12765387 17 Rheumatoid arthritis
127653871 12765387 18 Product used for unknown indication
127653871 12765387 19 Pain
127653871 12765387 20 Pain
127653871 12765387 21 Pain

Outcome of event

Event ID CASEID OUTC COD
127653871 12765387 DE
127653871 12765387 OT
127653871 12765387 LT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127653871 12765387 Circulatory collapse
127653871 12765387 Haemoglobin decreased
127653871 12765387 Inflammatory marker increased
127653871 12765387 Multiple fractures
127653871 12765387 Pelvic haematoma
127653871 12765387 Seizure

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found